Related Experiment Video

Updated: Jun 17, 2026

Generation of Cancer Cell Clones to Visualize Telomeric Repeat-containing RNA TERRA Expressed from a Single Telomere in Living Cells
09:13

Generation of Cancer Cell Clones to Visualize Telomeric Repeat-containing RNA TERRA Expressed from a Single Telomere in Living Cells

Published on: January 17, 2019

An evaluation cascade for G-quadruplex telomere targeting agents in human cancer cells

Mekala Gunaratnam1, Stephen Neidle

  • 1The Cancer Research UK Biomolecular Structure Group, The School of Pharmacy, University of London, London, UK.

Methods in Molecular Biology (Clifton, N.J.)
|December 10, 2009
PubMed

Insights

Small molecules targeting telomere DNA can form quadruplex structures to inhibit cancer cell growth. Assays evaluate compound activity for potential use in cancer xenograft models.

Area of Science:

  • Biochemistry
  • Biophysics
  • Cancer Biology

Background:

  • Telomerase and telomere maintenance are crucial in human cancer cells.
  • Small molecules can target telomeric DNA to form quadruplex structures.
  • Quadruplex formation inhibits telomerase enzyme activity, a key target in cancer therapy.

Purpose of the Study:

  • To describe biochemical, biophysical, and cellular assays for evaluating new anti-cancer compounds.
  • To assess the suitability of compounds for xenograft models of human cancer.
  • To investigate the mechanism of action of small molecules targeting telomeric DNA.

Main Methods:

  • Biochemical and biophysical assays to evaluate quadruplex stabilization properties.
  • Cellular assays assessing short- and long-term cell viability.
  • Measurement of telomerase enzymatic activity, cellular senescence, and telomere length changes.

Main Results:

  • The described assays provide a comprehensive evaluation of compound activity.
  • Compounds demonstrating effective quadruplex stabilization and anti-proliferative effects are identified.
  • Assessment of telomere length dynamics and senescence induction indicates therapeutic potential.

Conclusions:

  • The developed assay suite is effective for evaluating novel telomere-targeting cancer therapeutics.
  • Compounds that stabilize telomeric quadruplexes show promise for cancer treatment.
  • This methodology facilitates the progression of drug candidates to preclinical xenograft studies.

More Related Videos

Single-Molecule Fluorescence Visualization of DNA Polymerase Dynamics at G-Quadruplexes05:37

Single-Molecule Fluorescence Visualization of DNA Polymerase Dynamics at G-Quadruplexes

Published on: April 4, 2025

Analyzing Telomeric Protein-DNA Interactions Using Single-Molecule Magnetic Tweezers11:21

Analyzing Telomeric Protein-DNA Interactions Using Single-Molecule Magnetic Tweezers

Published on: August 30, 2024

Related Concept Videos

Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...